
LifeMD: A Derivative Beneficiary Of The Demand For Anti-Obesity Pharmaceuticals
LifeMD is positioned for rapid growth with the introduction of a weight management program and partnerships with Nutrisystem and Medifast. The company has seen an increase in new client signups for...

LifeMD, Inc. (LFMD) Q2 2023 Earnings Call Transcript
LifeMD, Inc. (NASDAQ:LFMD ) Q2 2023 Earnings Call Transcript August 9, 2023 4:30 PM ET Company Participants Justin Schreiber - Chairman and Chief Executive Officer Marc Benathen - Chief Financial O...
Related Companies
Related Articles